Vorinostat Completed Phase 1 Trials for Intraocular Lymphoma / Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue / Lymphomatous Involvement of Non-Cutaneous Extranodal Site / Recurrent Adult Diffuse Large Cell Lymphoma / Recurrent Mantle Cell Lymphoma / Recurrent Adult Lymphoblastic Lymphoma / Recurrent Grade 1 Follicular Lymphoma / Recurrent Grade 2 Follicular Lymphoma / Hepatosplenic T-Cell Lymphoma / Primary Cutaneous B-Cell Non-Hodgkin Lymphoma / Recurrent Non-Hodgkin Lymphoma / T-Cell Large Granular Lymphocyte Leukemia / Splenic Marginal Zone Lymphoma / Recurrent Adult Diffuse Mixed Cell Lymphoma / Waldenström's Macroglobulinemia (WM) / Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma / Recurrent Marginal Zone Lymphoma / Chronic Lymphocytic Leukemia (CLL) - Refractory / Recurrent Adult Acute Lymphoblastic Leukemia / Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma / Recurrent Adult Immunoblastic Lymphoma / Cutaneous B-Cell Non-Hodgkin Lymphoma / Refractory Hairy Cell Leukemia / Testicular Lymphoma / Recurrent Adult Burkitt Lymphoma / Adult B Acute Lymphoblastic Leukemia / Recurrent Small Lymphocytic Lymphoma / Angioimmunoblastic T-Cell Lymphoma / Adult T Acute Lymphoblastic Leukemia / Recurrent Grade 3 Follicular Lymphoma / Recurrent Adult Grade III Lymphomatoid Granulomatosis / Chronic Lymphocytic Leukaemia (CLL) / Recurrent Mycosis Fungoides and Sezary Syndrome / Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma / Recurrent Adult T-Cell Leukemia/Lymphoma / Nodal Marginal Zone Lymphoma / Recurrent Adult Hodgkin's Lymphoma / Anaplastic Large Cell Lymphoma / Recurrent Adult Diffuse Small Cleaved Cell Lymphoma / Small Intestinal Lymphoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01567709Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma